China Artificial Organs & Bionic Implants Market Size (2024 - 2029)

China Artificial Organs & Bionic Implants Market Analysis

The China artificial organs and bionic implants market is expected to register a CAGR of 11.7% during the forecast period.

• The outbreak of the pandemic impacted the market. The increasing number of organ failures due to COVID-19 increased the demand for artificial organs in China. For instance, according to a study published by National Center for Biotechnology Information (NCBI) in January 2022, in China, around 11.0% of COVID-19 patients exhibited short-term deterioration and later died of multiple organ dysfunction syndromes (MODS), including heart failure, acute renal injury, and shock. Therefore, such instances indicate that during the initial days of the pandemic, the demand for artificial organs was high in China.
• However, during the pandemic, the market for bionic implants was negatively impacted by the decline in accident and traffic injury cases. For instance, according to research published in ScienceDirect in July 2021, the overall number of traffic injuries in Suzhou, China, from January to May 2020, decreased due to the effects of COVID-19. However, with the ease of the lockdowns and restrictions, the market gained momentum and is expected to continue the upward trend over the forecast period.
• The increased incidence of disabilities and organ failures with the rising geriatric population and technological advancements leading to enhanced applications are the major drivers for the market.
• According to the study, diabetic foot ulcers are the leading cause of chronic wounds in hospitalized patients in China, occurring in as many as 8.1% of those with diabetes each year. The study also stated that the annual incidence of diabetic foot ulcers in China was as high as 8.1% in patients with diabetes, which ranked first among the causes of chronic wounds in hospitalized patients. The recurrence rate of foot ulcers in patients above 50 years with healed diabetic foot ulcers was as high as 31.6% within one year. Therefore, owing to increasing cases of disabilities, the demand for bionic implants is anticipated to increase in China, which may propel the market growth.
• The increasing number of accident cases in China and organ failures are also the major drivers for the market. According to the May 2022 World Health Rankings report, the accident rate in China in 2021 was 15.09%. Similarly, as per the February 2022 NCBI study, approximately 132.3 million people in China suffered from chronic kidney disease, and 2.8 million people received kidney transplantation in 2021. Such a high burden of accidents and chronic diseases is driving the market growth in the country.
• Therefore, the increasing number of accident cases leading to disabilities and organ failures in China is expected to surge the demand for bionic implants. Thus, the market is expected to show significant growth over the forecast period. However, the high cost of the procedures and fear of device malfunction and its consequences will likely hinder market growth over the forecast period.

China Artificial Organs & Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated into humans, to either replace a natural organ or provide support to restore a specific function or a group of related functions, helping the patient to return to his normal life.

The China artificial organs & bionic implants market is segmented by product (artificial organ (artificial heart, artificial kidney, and other artificial organs), bionics (vision bionics, ear bionics, orthopedic bionic, cardiac bionics, and other bionics)).

The report offers the value (in USD million) for the above segments.